Broad-spectrum coronavirus inhibition by RSV fusion inhibitors targeting six-helix bundle formation
Life Sciences · 2026-06 · 394 · 124357
DOI: 10.1016/j.lfs.2026.124357 ↗Kurz gefasst
Fachartikel in der Zeitschrift Life Sciences, 2026-06. Verfasst von Weiyi Chen und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Infectious Diseases and Public Health, Jockey Club College of Veterinary Medicine and Life Sciences, City University of Hong Kong, Hong…. Hauptthemen laut MEDLINE: Antiviral Agents, SARS-CoV-2, Virus Internalization, COVID-19 Drug Treatment. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 79 Literaturangaben. Gefördert von: Cornell University, Korea Institute of Planning and Evaluation for Technology in Food Agriculture Forestry and Fisheries, City University of Hong Kong.
Abstract (Originalsprache)
Waning vaccine-derived immunity and the emergence of new SARS-CoV-2 subvariants continue to challenge global public health, emphasizing the need for novel inhibitors against SARS-CoV-2 infection. Molecular inhibitors targeting virus entry are promising candidates as they can disrupt viral replication at the earliest stage. In this study, we utilized a fluorescence-based SARS-CoV-2 pseudovirus screening platform to identify entry inhibitors from a repurposed library of bioactive compounds. Ziresovir and TMC353121, both small molecules known as respiratory syncytial virus (RSV) fusion inhibitors, were identified as hits that inhibited SARS-CoV-2 pseudovirus entry. In vitro and in silico analyses, together with site-directed mutagenesis, demonstrated that these molecules interfere with the formation of the six-helix bundle (6HB) in the SARS-CoV-2 spike (S) protein, thereby inhibiting membrane fusion. Additionally, both compounds exhibited inhibitory effects against SARS-CoV pseudovirus, wild-type SARS-CoV-2, and several other coronaviruses. These findings identify Ziresovir and TMC353121 as mechanistically validated scaffolds that target conserved fusion mechanisms across different viral families. While further optimization is required to enhance their potency against infectious SARS-CoV-2, this study provides a strategic foundation and chemical templates for the development of broad-spectrum fusion inhibitors to combat current and future coronavirus threats.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Infectious Diseases and Public Health, Jockey Club College of Veterinary Medicine and Life Sciences, City University of Hong Kong, Hong Kong.
- Therapeutic and Biotechnology Division, Korea Research Institute of Chemical Technology, Daejeon, Republic of Korea.
- Department of Life Sciences, College of Life Sciences and Bioengineering, Incheon National University, Incheon, Republic of Korea.
- College of Veterinary Medicine, Yangzhou University, Yangzhou, 225009, China.
- MOE Joint International Research Laboratory of Animal Health and Food Safety, College of Veterinary Medicine, Nanjing Agricultural University, Nanjing, 210095, China.
- College of Veterinary Medicine, Konkuk University, Seoul, Republic of Korea. Electronic address: yunygo@konkuk.ac.kr.
Förderung
- Cornell University
- Korea Institute of Planning and Evaluation for Technology in Food Agriculture Forestry and Fisheries
- City University of Hong Kong
- National Institutes of Health
- National Institute of Allergy and Infectious Diseases
- Korea Research Institute of Chemical Technology
Zitieren
APA
Chen, W., Ji, M. C., Jung, E., Shin, J. S., Yeh, J. Y., Chen, Z., Zhou, B., & Go, Y. Y. (2026). Broad-spectrum coronavirus inhibition by RSV fusion inhibitors targeting six-helix bundle formation. Life Sciences, 394, 124357. https://doi.org/10.1016/j.lfs.2026.124357
Vancouver
Chen W, Ji MC, Jung E, Shin JS, Yeh JY, Chen Z, et al. Broad-spectrum coronavirus inhibition by RSV fusion inhibitors targeting six-helix bundle formation. Life Sciences. 2026;394:124357. doi:10.1016/j.lfs.2026.124357
BibTeX
@article{Chen2026,
author = {Chen, Weiyi and Ji, Min Chae and Jung, Eunhye and Shin, Jin Soo and Yeh, Jung-Yong and Chen, Zhenhai and Zhou, Bin and Go, Yun Young},
title = {Broad-spectrum coronavirus inhibition by RSV fusion inhibitors targeting six-helix bundle formation},
journal = {Life Sciences},
year = {2026},
volume = {394},
pages = {124357},
doi = {10.1016/j.lfs.2026.124357}
}
EUVIMED